Carriers of the rs12740374 variant, which is associated with increased hepatic sortilin expression, have been consistently shown to have decreased LDL-C and apoB levels, but the relative decrease has not been compared in a metabolic stressed condition, such as the presence of type 2 diabetes. This evidence concerns the gene SORT1 and type 2 diabetes mellitus.